Results 271 to 280 of about 80,266 (330)

A new era in chronic spontaneous urticaria: FDA approval of the oral BTK inhibitor remibrutinib. [PDF]

open access: yesAnn Med Surg (Lond)
Jan M   +5 more
europepmc   +1 more source

Discovery and structure-activity relationship of novel diphenylthiazole derivatives as BTK inhibitor with potent activity against B cell lymphoma cell lines

open access: green, 2019
Xiaofeng Guo   +9 more
openalex   +1 more source

BTK blocks the inhibitory effects of MDM2 on p53 activity

open access: diamond, 2017
Miran Rada   +7 more
openalex   +2 more sources

Altered PTPN13-β-catenin interaction by pathogenic mutations and involvement of this axis in B-cell receptor signalling. [PDF]

open access: yesSci Rep
Cabrera-Riofrío DA   +7 more
europepmc   +1 more source

Ibrutinib: The BTK Inhibitor Used for Hematologic Maligancies.

open access: hybrid
Monika Jain   +3 more
openalex   +1 more source

PLCG2 across human disease: genetic variants, signaling mechanisms, and clinical implications. [PDF]

open access: yesJ Transl Med
Jiang P   +8 more
europepmc   +1 more source

Preliminary Safety and Efficacy of Emavusertib (CA-4948) in Combination with Ibrutinib in Relapsed/Refractory Primary Central Nervous System Lymphoma Patients with Prior Exposure to BTK Inhibitor [PDF]

open access: bronze
Grzegorz S. Nowakowski   +15 more
openalex   +1 more source

Home - About - Disclaimer - Privacy